Navigation Links
David H. Murdock Research Institute Taps Waters for Laboratory Technology
Date:10/15/2008

Strategic Partnership Provides Advanced Technology for Groundbreaking

Nutrition and Disease Research

KANNAPOLIS, N.C. and MILFORD, Mass., Oct. 15 /PRNewswire-FirstCall/ -- The David H. Murdock Research Institute (DHMRI), located at the North Carolina Research Campus in Kannapolis, NC, and Waters Corporation (NYSE: WAT) announced today that Waters(R) has been selected as the institute's primary supplier of analytical science solutions, including mass spectrometers, liquid chromatographs and associated scientific data management software.

"We selected Waters as a partner based on their breakthrough technologies and hands-on approach to customer service. The equipment that we've purchased from Waters is recognized as the most sophisticated laboratory equipment available," said David H. Murdock, DHMRI founder. "This large purchase continues the momentum we're building as a cutting-edge research facility sought after by some of the nation's brightest scientists, and positions us well for the future."

The new laboratory instrumentation will enable DHMRI's research programs in the areas of nutrition science and disease prevention and provide state-of the-art capabilities in proteomics research and metabolic profiling, among other key application areas

"Our respective organizations have a similar focus on pushing the limits of scientific discovery and productivity, as well as collaboration," said Art Caputo, Executive Vice President and President of the Waters Division. "As with all our partners, we are pleased to be working closely with DHMRI to help make scientific discovery at the facility possible."

Among the new mass spectrometers purchased by DHMRI are a number of Waters(R) SYNAPT(TM) High Definition Mass Spectrometers -- the first commercially-available mass spectrometer with the ability to analyze ions by their size, shape and charge in addition to mass -- as well as the Waters Quattro Premier(TM) XE
'/>"/>

SOURCE Waters Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NSF International Acquires David Begg Associates
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
4. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
5. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
6. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
7. Immunosyn Corporation Names G. David Criner as CFO
8. Pasteuria Bioscience Taps New CEO David N. Duncan
9. David Mott Appointed Non Executive Director at Shire
10. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
11. Transgenomic Appoints David Pauluzzi to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email: